Total Payments
$91,234
2024 Payments
$95.15
Companies
29
Transactions
426
Medicare Patients
1,921
Medicare Billing
$188,216
Payment Breakdown by Category
Other$56,710 (62.2%)
Food & Beverage$12,296 (13.5%)
Travel$11,673 (12.8%)
Consulting$10,555 (11.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,510 | 18 | 37.8% |
| Honoraria | $22,200 | 9 | 24.3% |
| Food and Beverage | $12,296 | 337 | 13.5% |
| Travel and Lodging | $11,673 | 57 | 12.8% |
| Consulting Fee | $10,555 | 5 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pernix Therapeutics Holdings, Inc. | $23,770 | 49 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $21,954 | 62 | $0 (2021) |
| Depomed, Inc. | $19,079 | 51 | $0 (2017) |
| ASSERTIO THERAPEUTICS, Inc. | $11,530 | 23 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $4,415 | 25 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $4,218 | 46 | $0 (2021) |
| Amgen Inc. | $1,305 | 18 | $0 (2020) |
| Nevro Corp. | $927.97 | 12 | $0 (2022) |
| Medtronic USA, Inc. | $648.72 | 8 | $0 (2020) |
| PFIZER INC. | $458.59 | 30 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.15 | 1 | Medtronic, Inc. ($95.15) |
| 2023 | $164.47 | 2 | SI-BONE, INC. ($89.64) |
| 2022 | $341.84 | 3 | Medtronic, Inc. ($130.45) |
| 2021 | $522.61 | 15 | Abbott Laboratories ($147.69) |
| 2020 | $847.71 | 15 | Medtronic USA, Inc. ($275.72) |
| 2019 | $5,010 | 52 | Collegium Pharmaceutical, Inc. ($3,860) |
| 2018 | $29,616 | 134 | Assertio Therapeutics, Inc. ($11,485) |
| 2017 | $54,636 | 204 | Depomed, Inc. ($19,079) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $95.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/02/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $89.64 | General |
| 04/18/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $74.83 | General |
| 09/30/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $115.07 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/26/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $96.32 | General |
| Category: Pain Management | ||||||
| 04/20/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $130.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/15/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $92.75 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 11/10/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Chronic Pain | ||||||
| 11/03/2021 | Medtronic, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $62.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/12/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: Opioid Analgesic | ||||||
| 09/22/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $147.69 | General |
| Category: Neuromodulation | ||||||
| 09/21/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Opioid Analgesic | ||||||
| 09/09/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Chronic Pain | ||||||
| 08/11/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: Opioid Analgesic | ||||||
| 08/03/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Chronic Pain | ||||||
| 06/23/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Chronic Pain | ||||||
| 06/16/2021 | Medtronic, Inc. | Vanta (Device) | Food and Beverage | In-kind items and services | $55.03 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/13/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: Opioid Analgesic | ||||||
| 03/08/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Opioid Analgesic | ||||||
| 02/08/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: Opioid Analgesic | ||||||
| 01/13/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Opioid Analgesic | ||||||
| 12/14/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.77 | General |
| Category: Opioid Analgesic | ||||||
| 11/18/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Opioid Analgesic | ||||||
| 08/04/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Opioid Analgesic | ||||||
| 07/29/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $52.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 341 | 649 | $285,637 | $35,672 |
| 2022 | 8 | 468 | 869 | $332,004 | $44,432 |
| 2021 | 13 | 555 | 986 | $402,598 | $61,129 |
| 2020 | 14 | 557 | 931 | $373,183 | $46,983 |
Total Patients
1,921
Total Services
3,435
Medicare Billing
$188,216
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 136 | 359 | $97,648 | $15,311 | 15.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 60 | 104 | $65,416 | $7,264 | 11.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 24 | 41 | $43,371 | $3,941 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 54 | $22,626 | $3,470 | 15.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 40 | 40 | $14,040 | $2,294 | 16.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 14 | 21 | $26,928 | $1,616 | 6.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $7,839 | $1,102 | 14.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 12 | 17 | $7,769 | $672.69 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 146 | 375 | $92,611 | $17,916 | 19.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 61 | 117 | $66,924 | $8,358 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 70 | 90 | $34,290 | $6,414 | 18.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 33 | 47 | $46,512 | $4,532 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 24 | 24 | $13,152 | $2,354 | 17.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 19 | 31 | $31,280 | $1,989 | 6.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 30 | 30 | $9,570 | $1,531 | 16.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 85 | 155 | $37,665 | $1,339 | 3.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 170 | 423 | $101,520 | $22,261 | 21.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 88 | 152 | $84,360 | $11,836 | 14.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 58 | 69 | $25,530 | $5,790 | 22.7% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 30 | 51 | $50,160 | $5,560 | 11.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 47 | 47 | $14,993 | $3,103 | 20.7% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Facility | 2021 | 17 | 34 | $36,300 | $2,908 | 8.0% |
| 62321 | Injection of substance into spinal canal of upper or middle back using imaging guidance | Facility | 2021 | 20 | 36 | $23,364 | $2,858 | 12.2% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 12 | 20 | $18,574 | $2,016 | 10.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $9,316 | $1,820 | 19.5% |
About Dr. Riad Laham, MD
Dr. Riad Laham, MD is a Pain Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316900210.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riad Laham, MD has received a total of $91,234 in payments from pharmaceutical and medical device companies, with $95.15 received in 2024. These payments were reported across 426 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,510).
As a Medicare-enrolled provider, Laham has provided services to 1,921 Medicare beneficiaries, totaling 3,435 services with total Medicare billing of $188,216. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology
- Location Cleveland, OH
- Active Since 04/11/2006
- Last Updated 02/01/2008
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1316900210
Products in Payments
- ZOHYDRO ER (Drug) $23,637
- BELBUCA (Drug) $21,720
- Nucynta (Drug) $19,937
- Gralise (Drug) $11,679
- Horizant (Drug) $4,415
- Lazanda (Drug) $2,684
- Aimovig (Biological) $1,020
- Senza Spinal Cord Stimulation System (Device) $812.90
- INTELLIS (Device) $498.14
- LYRICA (Drug) $451.82
- LORZONE (Drug) $338.10
- XTAMPZA (Drug) $304.36
- BUNAVAIL 2.1 mg 30-count box (Drug) $234.49
- TRITANIUM (Device) $231.93
- INTELLIS ADAPTIVESTIM (Device) $225.60
- BRIDION (Drug) $214.54
- PENNSAID (Drug) $189.91
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $157.24
- Proclaim IPG (Device) $147.69
- SYNCHROMED (Device) $126.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Cleveland
Nagy Mekhail, Md, MD
Pain Medicine — Payments: $1.3M
Pain Medicine $1.3M
Dr. Robert Bolash, M.d, M.D
Pain Medicine — Payments: $231,217
Pain Medicine $231,217
Edward Covington, M.d, M.D
Pain Medicine — Payments: $46,495
Pain Medicine $46,495
Dr. Aman Upadhyay, M.d, M.D
Pain Medicine — Payments: $43,301
Pain Medicine $43,301
Jianguo Cheng, Md Phd, MD PHD
Pain Medicine — Payments: $41,082
Pain Medicine $41,082
Dr. Kush Goyal, M.d, M.D
Pain Medicine — Payments: $21,137
Pain Medicine $21,137